Concise Prescribing Info Bahasa Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Indications/Uses

RITUXSANBE is indicated for the treatment of Non-Hodgkin's lymphoma (NHL):
Relapsed or chemoresistant low-grade or follicular, CD20-positive, B-cell Non-Hodgkin's lymphoma.
Patients with stage III-IV follicular lymphoma in combination with CVP chemotherapy.
Patients with follicular lymphoma as maintenance treatment, after response to induction therapy.
Patients with CD20-positive diffuse large B-cell Non-Hodgkin's lymphoma in combination with CHOP chemotherapy.

Rituxsanbe Indications/Uses

rituximab

Manufacturer:

Sanbe

Marketer:

Sanbe